Paper published in a journal (Scientific congresses and symposiums)
3-R/S-(hydroxyalkylamino)-4H-1,2,4-benzothiadiazine 1,1-dioxides as potential K+ATP channel activators: influence of stereochemistry on biological activity and tissue selectivity
Boverie, S.; Becker, B.; Somers, F. et al.
2002In Fundamental and Clinical Pharmacology, p. 69
Peer Reviewed verified by ORBi
 

Files


Full Text
Fund. Clin. Pharm. 2002, 16, 67-71.pdf
Publisher postprint (113.72 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Boverie, S.;  Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Becker, B.;  Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Somers, F.
Nguyen, Q. A.
Ouedraogo, R.
Antoine, M. H.
Lebrun, P.
Pirotte, Bernard 
De Tullio, Pascal 
Language :
English
Title :
3-R/S-(hydroxyalkylamino)-4H-1,2,4-benzothiadiazine 1,1-dioxides as potential K+ATP channel activators: influence of stereochemistry on biological activity and tissue selectivity
Publication date :
2002
Audience :
International
Journal title :
Fundamental and Clinical Pharmacology
ISSN :
0767-3981
eISSN :
1472-8206
Publisher :
Blackwell Science, Oxford, United Kingdom
Special issue title :
16
Pages :
69
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 11 September 2009

Statistics


Number of views
27 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi